EUVIMEDEUVIMED entdecken
LeserbriefKommentarOpen Access

Reply: Radiopharmaceutical Extravasations CanHave Consequences

Ashwin Singh Parihar, Lisa Raymond-Schmidt, John P Crandall, Farrokh Dehdashti, Richard L Wahl

Journal of Nuclear Medicine · 2023

DOI: 10.2967/jnumed.123.265920 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Nuclear Medicine, 2023. Verfasst von Ashwin Singh Parihar und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Extravasation of Diagnostic and Therapeutic Materials. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

REPLY: We would like to thank the author for his interest in our work and for this opportunity to address his queries. The author raises several concerns about our large retrospective study. We had described a limitation of our methodology that involved reviewing the clinical reports for reported

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiopharmaceuticalsExtravasation of Diagnostic and Therapeutic MaterialsHumans

Substanzen

Radiopharmaceuticals

Zitieren

APA

Parihar, A. S., Raymond-Schmidt, L., Crandall, J. P., Dehdashti, F., & Wahl, R. L. (2023). Reply: Radiopharmaceutical Extravasations CanHave Consequences. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.265920

Vancouver

Parihar AS, Raymond-Schmidt L, Crandall JP, Dehdashti F, Wahl RL. Reply: Radiopharmaceutical Extravasations CanHave Consequences. Journal of Nuclear Medicine. 2023. doi:10.2967/jnumed.123.265920

BibTeX
@article{Parihar2023,
  author = {Parihar, Ashwin Singh and Raymond-Schmidt, Lisa and Crandall, John P and Dehdashti, Farrokh and Wahl, Richard L},
  title = {Reply: Radiopharmaceutical Extravasations CanHave Consequences},
  journal = {Journal of Nuclear Medicine},
  year = {2023},
  doi = {10.2967/jnumed.123.265920}
}
Kostenlos starten →